Align Technology, Inc. (ALGN)

Market Cap	10.84B
Revenue (ttm)	3.96B
Net Income (ttm)	437.61M
Shares Out	72.49M
EPS (ttm)	5.92
PE Ratio	25.35
Forward PE	14.22
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,499,050
Open	141.10
Previous Close	140.67
Day's Range	141.10 - 150.22
52-Week Range	127.70 - 262.87
Beta	1.61
Analysts	Buy
Price Target	216.25 (+44.58%)
Earnings Date	Jul 30, 2025

About ALGN

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package to treat adults and teens from mild to severe malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1997
• Employees: 20,945
• Stock Exchange: NASDAQ
• Ticker Symbol: ALGN
• Website: https://www.aligntech.com

Financial Performance

In 2024, Align Technology's revenue was $4.00 billion, an increase of 3.54% compared to the previous year's $3.86 billion. Earnings were $421.36 million, a decrease of -5.32%.

Analyst Summary

According to 13 analysts, the average rating for ALGN stock is "Buy." The 12-month stock price target is $216.25, which is an increase of 44.58% from the latest price.

Price Target

$216.25

(44.58% upside)

Analyst Consensus: Buy